Dr. Rajasree P. Chowdry
Claim this profileUniversity Medical Center New Orleans
Affiliated Hospitals
University Medical Center New Orleans
East Jefferson General Hospital
Clinical Trials Rajasree P. Chowdry is currently running
Relugolix + Radiation
for Advanced-Stage Prostate Cancer
This phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with castration-sensitive prostate cancer that has spread to limited other parts of the body (oligometastatic). Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. It may stop the growth of cancer cells that need testosterone to grow. Radiation therapy uses high-energy x rays or protons to kill tumor cells. The addition of relugolix to the radiation may reduce the chance of oligometastatic prostate cancer spreading further.
Recruiting
0 awards
Phase 2
Durvalumab + Chemotherapy
for Urothelial Carcinoma
This phase II/III trial compares the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper urinary tract cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Durvalumab in combination with chemotherapy before surgery may enhance the shrinking of the tumor compared to chemotherapy alone.
Recruiting
1 award
Phase 2 & 3
10 criteria
More about Rajasree P. Chowdry
Clinical Trial Related
2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Rajasree P. Chowdry has experience with
- Nivolumab
- Carboplatin
- Paclitaxel
- Cabozantinib
- Ipilimumab
- Atezolizumab
Breakdown of trials Rajasree P. Chowdry has run
Renal Cell Carcinoma
Kidney Cancer
Anal Cancer
Anal Canal Cancer
Anal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rajasree P. Chowdry specialize in?
Rajasree P. Chowdry focuses on Renal Cell Carcinoma and Kidney Cancer. In particular, much of their work with Renal Cell Carcinoma has involved Stage IV patients, or patients who are undergoing treatment.
Is Rajasree P. Chowdry currently recruiting for clinical trials?
Yes, Rajasree P. Chowdry is currently recruiting for 2 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Rajasree P. Chowdry has studied deeply?
Yes, Rajasree P. Chowdry has studied treatments such as Nivolumab, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Rajasree P. Chowdry?
Apply for one of the trials that Rajasree P. Chowdry is conducting.
What is the office address of Rajasree P. Chowdry?
The office of Rajasree P. Chowdry is located at: University Medical Center New Orleans, New Orleans, Louisiana 70112 United States. This is the address for their practice at the University Medical Center New Orleans.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.